ProShare Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,009
| Closed | -$677K | – | 1829 |
|
|
2022
Q2 | $677K | Sell |
9,009
-4,751
| -35% | -$357K | ﹤0.01% | 847 |
|
|
2022
Q1 | $370K | Sell |
13,760
-3,250
| -19% | -$87.4K | ﹤0.01% | 1492 |
|
|
2021
Q4 | $810K | Buy |
17,010
+560
| +3% | +$26.7K | ﹤0.01% | 1157 |
|
|
2021
Q3 | $1.09M | Sell |
16,450
-4,311
| -21% | -$286K | ﹤0.01% | 879 |
|
|
2021
Q2 | $1.62M | Buy |
20,761
+4,117
| +25% | +$321K | ﹤0.01% | 796 |
|
|
2021
Q1 | $1.57M | Buy |
16,644
+939
| +6% | +$88.8K | ﹤0.01% | 776 |
|
|
2020
Q4 | $1.91M | Buy |
15,705
+4,721
| +43% | +$575K | 0.01% | 648 |
|
|
2020
Q3 | $960K | Buy |
10,984
+592
| +6% | +$51.7K | ﹤0.01% | 730 |
|
|
2020
Q2 | $671K | Buy |
10,392
+3,835
| +58% | +$248K | ﹤0.01% | 827 |
|
|
2020
Q1 | $293K | Sell |
6,557
-4,948
| -43% | -$221K | ﹤0.01% | 883 |
|
|
2019
Q4 | $717K | Buy |
+11,505
| New | +$717K | ﹤0.01% | 924 |
|